0.55 USD
↗ 0.06 (9.47%)PRE MARKET (AS OF 04:01 AM EDT)
Barinthus Biotherapeutics plc American Depositary Shares
BRNSNASDAQ • USD
Market: OPEN
Open?$0.65
High?$0.65
Low?$0.65
Prev. Close?$0.59
Volume?519
Avg. Volume?28.2K
VWAP?$0.65
Rel. Volume?0.02x
Bid / Ask
Bid?$0.55 × 100
Ask?$0.61 × 100
Spread?$0.06
Midpoint?$0.58
Valuation & Ratios
Market Cap?24.1M
Shares Out?40.8M
P/E Ratio?N/A
P/B Ratio?0.32
EPS?-$1.63
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?7.63Strong
Quick Ratio?7.63Strong
Cash Ratio?7.03Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?0.32CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.8CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-89.5%WEAK▾
ROA?-67.7%WEAK▾
Cash Flow & Enterprise
FCF?$-48016000
Enterprise Value?$-46355153
Related Companies
Loading...
News
Profile
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.
Employees
14
Market Cap
24.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-04-30
Address
20400 CENTURY BLVD
GERMANTOWN, MD 20874
Phone: 44 (0) 1865 818808
GERMANTOWN, MD 20874
Phone: 44 (0) 1865 818808